University of Virginia Library

Search this document 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DELEGATION OF AUTHORITY TO SELL THE ASSETS OF THE NEUROCLINICAL TRIALS CENTER
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

DELEGATION OF AUTHORITY TO SELL THE ASSETS OF THE NEUROCLINICAL TRIALS CENTER

The following resolution was adopted:

  • WHEREAS, The Neuroclinical Trials Center, a division of the Virginia Neurological Institute, manages clinical trials on neurological drug therapies for pharmaceutical companies; and
  • WHEREAS, the managing of clinical trials is not central to the mission of the University Health Sciences Center; and
  • WHEREAS, the University is negotiating with potential purchasers of the assets of the division, who will then operate the business as a private, for-profit enterprise;
  • RESOLVED that, with the review and approval of a subcommittee of the Board convened by the Rector, and in consultation with the General Counsel, the Executive Vice President and Chief Financial Officer is authorized to enter into a sale of the assets of the Neuroclinical Trials Center; provided, any such transaction shall be reported to the Board of Visitors at its next regular meeting;
  • RESOLVED FURTHER, the foregoing shall expire on June 30, 1998, unless extended by the Board of Visitors.